IRAS, a candidate for I1-imidazoline receptor, mediates inhibitory effect of agmatine on cellular morphine dependence

Biochemical Pharmacology

Volumn 70, Issue 7, 2005, Pages 1079-1087

  Wu, Ning ^a   Su, Rui Bin ^a   Xu, Bo ^a   Lu, Xin Qiang ^a   Liu, Yin ^a   Zheng, Jian Quan ^a   Piletz, John E ^b   Li, Jin ^a   Qin, Bo Yi ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^b Jackson State University   (United States)

Author keywords

Agmatine; cAMP overshoot; Imidazoline receptor; IRAS; Opioid dependence

Indexed keywords

AGMATINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CYCLIC AMP; EFAROXAN; FORSKOLIN; IMIDAZOLINE I1 RECEPTOR; IMIDAZOLINE RECEPTOR; IMIDAZOLINE RECEPTOR ANTISERUM SELECTED PROTEIN; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NIFEDIPINE; PROTEIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; 2 (2 IMIDAZOLIN 2 YL)QUINOLINE; DIZOCILPINE MALEATE; IMIDAZOLE DERIVATIVE; N(G) NITROARGININE METHYL ESTER; NISCH PROTEIN, HUMAN; NITRIC OXIDE SYNTHASE; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENETIC TRANSFECTION; MOLECULAR MIMICRY; MORPHINE ADDICTION; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REACTION TIME; ANIMAL; HAMSTER; METABOLISM; PHYSIOLOGY;

AGMATINE; ANIMALS; CHO CELLS; CRICETINAE; CYCLIC AMP; DIZOCILPINE MALEATE; IMIDAZOLES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MORPHINE; NALOXONE; NG-NITROARGININE METHYL ESTER; NIFEDIPINE; NITRIC OXIDE SYNTHASE;

EID: 24344472244     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2005.07.006     Document Type: Article

References (43)

1. J.T. Williams, M.J. Christie, and O. Manzoni Cellular and synaptic adaptations mediating opioid dependence Physiol Rev 81 2001 299 345
2. C.A. Heidbreder, and J.J. Hagan Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving Curr Opin Pharmacol 5 2005 107 118
3. Y. Kolesnikov, S. Jain, and G.W. Pasternak Modulation of opioid analgesia by agmatine Eur J Pharmacol 296 1996 17 22
4. J. Li, X. Li, G. Pei, and B.Y. Qin Analgesic effect of agmatine and its enhancement on morphine analgesia in mice and rats Acta Pharmacol Sin 20 1999 81 85
5. J. Li, X. Li, G. Pei, and B.Y. Qin Effects of agmatine on tolerance to and substance dependence on morphine in mice Acta Pharmacol Sin 20 1999 232 238
6. F. Aricioglu-Kartal, and I.T. Uzbay Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats Life Sci 61 1997 1775 1781
7. R.B. Su, J. Li, and B.Y. Qin A biphasic opioid function modulator: agmatine Acta Pharmacol Sin 24 2003 631 636
8. D.J. Reis, and S. Regunathan Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 21 2000 187 193
9. M.C. Michel, and P. Ernsberger Keep an eye on I sites: imidazoline-preferring receptors Trends Pharmacol Sci 13 1992 369 370
10. D.A. Ruggiero, S. Regunathan, H. Wang, T. Milner, and D.J. Reis Immunocytochemical localization of an imidazoline receptor protein in the central nervous system Brain Res 780 1998 270 293
11. F. Georges, and G. Aston-Jones Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors Neuropsychopharmacology 28 2003 1140 1149
12. V. Bruban, J. Feldman, H. Greney, M. Dontenwill, S. Shann, and C. Jarry Respective contributions of a-adrenergic and non-adrenergic mechanism in the hypotensive effect of imidazoline-like drugs Br J Pharmacol 133 2001 261 266
13. S. Schann, V. Bruban, K. Pompermayer, J. Feldman, B. Pfeiffer, and P. Renard Synthesis and biological evaluation of pyrrolinic isosteres of rilmenidine. Discovery of cis-/trans-dicyclopropylmethyl-(4,5-dimethyl-4,5- dihydro-3H-pyrrol-2-yl)-amine (LNP 509), an I1 imidazoline receptor selective ligand with hypotensive activity J Med Chem 44 2001 1588 1593
14. D. Urosevic, S. Schann, J.D. Ehrhardt, P. Bousquet, and H. Greney LNP 906 the first high-affinity photoaffinity ligand selective I1 imidazoline receptors Br J Pharmacol 142 2004 609 617
15. J.E. Piletz, T.R. Ivanov, J.D. Sharp, P. Ernsberger, C.H. Chang, and R.T. Pickard Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization DNA Cell Biol 19 2000 319 329
16. S.K. Alahari, J.W. Lee, and R.L. Juliano Nischarin, a novel protein that interacts with the integrin α5 subunit and inhibits cell migration J Cell Biol 151 2000 1141 1154
17. J.E. Piletz, J.C. Jones, H. Zhu, O. Bishara, and P. Ernsberger Imidazoline receptor antisera-selected cDNA clone and mRNA distribution Ann NY Acad Sci 881 1999 1 7
18. J. Li, P. Huang, C.G. Chen, K. Riel, H. Weinstein, and L.Y. Liu-chen Constitutive activation of the μ opioid receptor by mutation of D3.49(164), but not D3.32(147): D3.49(164) is critical for stabilization of the inactive form of the receptor and for its expression Biochemistry 40 2001 12039 12050
19. J. Li, X. Li, G. Pei, and B.Y. Qin Correlation between inhibitions of morphine withdrawal and nitric-oxide synthase by agmatine Acta Pharmacol Sin 20 1999 375 380
20. 2-adrenergic receptor in Chinese hamster ovary cells. Evidence for independent pathways of receptor coupling to adenylate cyclase attenuation and activation J Biol Chem 264 1989 11754 11761
21. 1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes J Pharmacol Exp Ther 279 1996 694 702
22. G. Li, S. Regunathan, C.J. Barrow, J. Eshraghi, R. Cooper, and D.J. Reis Agmatine: an endogenous clonidine-displacing substance in the brain Science 263 1994 966 969
23. 1-imidazoline receptor in PC12 pheochromocytoma cells reverses NGF-induced ERK activity and induces MPK-2 phosphatase Brain Res 980 2003 71 79
24. 1 receptor-induced activation of phosphatigylcholine-specific phospholipase C elicits mitogen-activated protein kinase phosphorylation in PC12 cells Eur J Pharmacol 415 2001 117 125
25. Y. Zhao, R.B. Su, N. Wu, B. Xu, Y. Liu, and X.Q. Lu Stable expression of imidazoline-1 receptor in mammalian cells Bull Acad Mil Med Sci 28 2004 333 336
26. K. Fukuda, S. Kato, K. Mori, M. Nishi, and H. Takeshima Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes FEBS Lett 327 1993 311 314
27. K. Raynor, H. Kong, Y. Chen, K. Yasuda, L. Yu, and G.I. Bell Pharmacological characterization of the cloned κ-, δ-, and μ- opioid receptors Mol Pharmacol 45 1994 330 334
28. P.S. Johnson, J.B. Wang, W.F. Wang, and G.R. Uhl Expressed μ opiate receptor couples to adenylate cyclase and phosphatidyl inositol turnover Neuroreport 5 1994 507 509
29. T. Avidor-Reiss, M. Bayewitch, R. Levy, N. Matus-Leibovitch, I. Nevo, and Z. Vogel Adenylylcyclase supersensitization in μ-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment J Biol Chem 270 1995 29732 29738
30. S. Uchino, W. Watanabe, T. Nakamura, S. Shuto, Y. Kazuta, and A. Matsuda Establishment of CHO cell lines expressing four N-methyl-d-aspartate receptor subtypes and characterization of a novel antagonist PPDC FEBS Lett 506 2001 117 122
31. X.C. Yang, and D.J. Reis Agmatine selectively blocks the NMDA subclass of glutamate receptor channels in cultured mouse hippocampal neurons J Pharmacol Exp Ther 288 1999 544 549
32. E. Galea, S. Regunathan, V. Eliopoulos, D.J. Feinstein, and D.J. Reis Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine Biochem J 316 1996 247 249
33. P. Valeri, B. Martinelli, G. Pimpinella, and C. Severini Effects of dapiprazole, clonidine and yohimbine on the development of dependence and withdrawal behaviour in mice Drug Alcohol Depend 23 1989 73 77
34. N.H. Majeed, B. Przewlocka, H. Machelska, and R. Przewlocki Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice Neuropharmacology 33 1994 189 192
35. K.A. Trujillo, and H. Akil Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801 Science 251 1991 85 87
36. E. Ruiz-Durantez, M. Torrecilla, J. Pineda, and L. Ugedo Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline in rat locus coeruleus neurons Br J Pharmacol 138 2003 494 500
37. M. Sastre, P. Ventayol, and J.A. Garcia-Sevilla Decreased density of I2-imidazoline receptors in the postmortem brain of heroin addicts Neuroreport 7 1996 509 512
38. R. Skryma, N. Prevarskaya, P. Vacher, and B. Dufy Voltage-dependent ionic conductances in Chinese hamster ovary cells Am J Physiol 267 1994 C544 C553
39. 3H] nitrendipine binding to the voltage-sensitive calcium channel in rat brain Eur J Pharmacol 225 1992 167 169
40. 2+ channels Brain Res 932 2002 25 36
41. X.C. Weng, X.D. Gai, J.Q. Zheng, and J. Li Agmatine blocked voltage-gated calcium channel in cultured rat hippocampal neurons Acta Pharmacol Sin 24 2003 746 750
42. V. Ramkumar, and E.E. El-Fakahany Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence Eur J Pharmacol 146 1988 73 83
43. M. Conner, and G. Henderson δ- and μ-opioid receptor modulate moblization of intracellular calcium in SH-SY5Y human neuroblastoma cells Br J Pharmacol 117 1996 333 340